- ACCOUNT ACCESS
-
CONTACT US
Pre-Sales Support
Mutual Funds and ETFs - 800-456-7526
Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
Friday: 8:00 a.m. – 5:00 p.m. ETPost-Sales and Website Support
888-843-7824
Monday-Friday: 9:00 a.m. - 6:00 p.m. ET- PHONE US MAIL US
- ADVISOR LOG IN
Objective
Seeks long-term capital appreciation.
Overview
A highly diversified international equity fund with a focus on value companies of high quality.
Portfolio Management
Portfolio Manager
11
YRS
MANAGING THIS FUND
19
YRS
AT SCHRODERS
23
YRS
EXPERIENCE IN THIS INDUSTRY
Portfolio Manager
4
YRS
MANAGING THIS FUND
18
YRS
AT SCHRODERS
32
YRS
EXPERIENCE IN THIS INDUSTRY
Portfolio Manager
1
YRS
MANAGING THIS FUND
5
YRS
AT SCHRODERS
17
YRS
EXPERIENCE IN THIS INDUSTRY
The portfolio managers are supported by the full resources of Schroders.
Performance
PERFORMANCE %
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
SI = Since Inception.
Fund Inception: 08/30/2006
Performance prior to 10/24/16 for Class I-shares reflects the performance, fees, and expenses of the Investor Class of the predecessor fund Schroder International Multi-Cap Value Fund. If Class I fees and expenses were reflected, performance would have differed. SI performance is calculated from 8/30/06.
Hartford Schroders International Multi-Cap Value Fund I Share Morningstar Ratings
overall
(as of 10/31/2022)
Overall, 4 stars, 3-Year, 3 stars, 5-Year, 3 stars, and 10-Year, 4 stars, rated against 315, 315, 294 and 175 products, respectively. Morningstar RatingTM
is calculated for products with at least a 3-year history, based on a risk-adjusted return measure (excluding any applicable sale charges) and accounts for variations in a product's monthly performance. 5 stars are assigned to the top 10%; 4 stars to the next 22.5%, 3 stars to the next 35%, 2 stars to the next 22.5% and 1 star to the bottom 10%. ETFs and mutual funds are considered a single population. The Overall Rating is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. For more information about these ratings, including their methodology, please go to global.morningstar.com/managerdisclosures
. Ratings for other share classes may vary and are subject to change monthly. Past performance is no guarantee of future performance.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
315 PRODUCTS
|
Foreign Large Value Category
Based on Risk-Adjusted Returns
3 YEAR
(as of 10/31/2022)
Overall, 4 stars, 3-Year, 3 stars, 5-Year, 3 stars, and 10-Year, 4 stars, rated against 315, 315, 294 and 175 products, respectively. Morningstar RatingTM
is calculated for products with at least a 3-year history, based on a risk-adjusted return measure (excluding any applicable sale charges) and accounts for variations in a product's monthly performance. 5 stars are assigned to the top 10%; 4 stars to the next 22.5%, 3 stars to the next 35%, 2 stars to the next 22.5% and 1 star to the bottom 10%. ETFs and mutual funds are considered a single population. The Overall Rating is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. For more information about these ratings, including their methodology, please go to global.morningstar.com/managerdisclosures
. Ratings for other share classes may vary and are subject to change monthly. Past performance is no guarantee of future performance.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
315 PRODUCTS
|
Foreign Large Value Category
Based on Risk-Adjusted Returns
5 YEAR
(as of 10/31/2022)
Overall, 4 stars, 3-Year, 3 stars, 5-Year, 3 stars, and 10-Year, 4 stars, rated against 315, 315, 294 and 175 products, respectively. Morningstar RatingTM
is calculated for products with at least a 3-year history, based on a risk-adjusted return measure (excluding any applicable sale charges) and accounts for variations in a product's monthly performance. 5 stars are assigned to the top 10%; 4 stars to the next 22.5%, 3 stars to the next 35%, 2 stars to the next 22.5% and 1 star to the bottom 10%. ETFs and mutual funds are considered a single population. The Overall Rating is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. For more information about these ratings, including their methodology, please go to global.morningstar.com/managerdisclosures
. Ratings for other share classes may vary and are subject to change monthly. Past performance is no guarantee of future performance.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
294 PRODUCTS
|
Foreign Large Value Category
Based on Risk-Adjusted Returns
10 YEAR
(as of 10/31/2022)
Overall, 4 stars, 3-Year, 3 stars, 5-Year, 3 stars, and 10-Year, 4 stars, rated against 315, 315, 294 and 175 products, respectively. Morningstar RatingTM
is calculated for products with at least a 3-year history, based on a risk-adjusted return measure (excluding any applicable sale charges) and accounts for variations in a product's monthly performance. 5 stars are assigned to the top 10%; 4 stars to the next 22.5%, 3 stars to the next 35%, 2 stars to the next 22.5% and 1 star to the bottom 10%. ETFs and mutual funds are considered a single population. The Overall Rating is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. For more information about these ratings, including their methodology, please go to global.morningstar.com/managerdisclosures
. Ratings for other share classes may vary and are subject to change monthly. Past performance is no guarantee of future performance.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
©2022 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
175 PRODUCTS
|
Foreign Large Value Category
Based on Risk-Adjusted Returns
Characteristics
FUND STATS
| # of Holdings | 506 |
| Turnover- (9/30/2022) | 97% |
| Active Share | 81% |
Holdings Characteristics
| FUND | MSCI ACWI ex USA Index | |
|---|---|---|
| Price/Earnings | 7.6x | 10.7x |
| Price/Book | 1.2x | 1.6x |
| Asset Weighted Market Cap (billions) | $45.2 | $69.3 |
| Median Market Cap (billions) | $4.5 | $7.4 |
| Return on Equity | 13.1% | 14.0% |
Regional Exposure (%)
Top Ten Holdings (%)
| Shell plc | 1.48 |
| AstraZeneca plc | 1.34 |
| Novartis AG | 1.31 |
| Sanofi | 1.31 |
| Ono Pharmaceutical Co., Ltd. | 1.26 |
| Equinor ASA | 1.25 |
| KDDI Corp. | 1.22 |
| Koninklijke KPN N.V. | 1.20 |
| Reckitt Benckiser Group plc | 1.16 |
| Astellas Pharma, Inc. | 1.14 |
| Total Portfolio % | 12.67 |
Market Cap Distribution (%)
| Less than $1 billion | 3 | |
| $1 billion - $5 billion | 16 | |
| $5 billion - $20 billion | 33 | |
| Greater than $20 billion | 48 | |
| Not Classified | 0 | |
RETURN CHARACTERISTICS
|
Alpha (5 Year)
|
-0.17 |
|
Down Capture (5 Year)
|
105.28 |
|
Information Ratio (5 Year)
|
-0.09 |
|
Sharpe Ratio (5 Year)
|
-0.04 |
|
Up Capture (5 Year)
|
103.69 |
Sector Exposure (%)
FUND |
BENCHMARK | UNDERWEIGHT / OVERWEIGHT | |||||
|---|---|---|---|---|---|---|---|
| 9/30/22 | 10/31/22 | 10/31/22 | -7 0 7 | ||||
| Communication Services | 13 | 13 | 6 | ||||
| Energy | 11 | 12 | 7 | ||||
| Utilities | 4 | 4 | 3 | ||||
| Financials | 21 | 21 | 21 | ||||
| Health Care | 10 | 10 | 10 | ||||
| Consumer Discretionary | 10 | 10 | 11 | ||||
| Materials | 9 | 7 | 8 | ||||
| Real Estate | 1 | 1 | 2 | ||||
| Consumer Staples | 4 | 6 | 9 | ||||
| Information Technology | 7 | 7 | 11 | ||||
| Industrials | 7 | 7 | 13 | ||||
Based on Global Industry Classification Standard (GICS), which was developed by and is the exclusive property and a service mark of MSCI Inc. (MSCI) and Standard & Poor's, a division of The McGraw-Hill Companies, Inc. (S&P). Excludes cash. May not total to 100% due to rounding and/or pooled vehicle allocations.
distributions and capital gains
| Distribution Date | Distribution NAV | ordinary income | short term capital gains | long term capital gains | total distribution |
|---|---|---|---|---|---|
| 9/29/2022 | 7.86 | $0.0548 | $0.0000 | $0.0000 | $0.0548 |
| 6/29/2022 | 9.01 | $0.0956 | $0.0000 | $0.0000 | $0.0956 |
| 3/30/2022 | 10.22 | $0.0472 | $0.0000 | $0.0000 | $0.0472 |
| 12/30/2021 | 10.27 | $0.1142 | $0.0000 | $0.0000 | $0.1142 |
| 12/13/2021 | 10.22 | $0.0000 | $0.0000 | $0.0000 | $0.0000 |
Past distributions are not indicative of future distributions.
Insights
Fund Literature
This Fund Fact Sheet summarizes the Fund's investment approach, portfolio statistics, top holdings, and current performance.
09/30/2022 - PDF (218 KB)
This flyer highlights the key attributes of a highly diversified, multi-cap value approach that investors should consider when selecting an international equity strategy.
09/30/2022 - PDF (366 KB)
Current quarterly commentary from sub-adviser, Schroders, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund.
PDF (147 KB)
A summary of a fund's full-length prospectus that provides key information potential investors should consider before making an investment decision.
09/30/2022 - PDF (761 KB)
This Pitchbook reviews the Fund's investment approach, investment team, investment process, portfolio statistics, top holdings, and the current performance.
PDF (4 KB)
An unaudited financial report, which includes a fund's financial statements. These reports are intended for shareholders and others who have reviewed the fund's prospectus.
PDF (13 KB)
A legal document that discloses essential information about a fund, including investment objectives, risks, fees, expenses, fund manager background and other information.
PDF (4 KB)
An audited financial report, which includes a fund's financial statements. These reports are intended for shareholders and others who have reviewed the fund's prospectus.
Important Risks: Investing involves risk, including the possible loss of principal. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political, economic and regulatory developments. These risks may be greater, and include additional risks, for investments in emerging markets or if the Fund focuses in a particular geographic region or country. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities. • Different investment styles may go in and out of favor, which may cause the Fund to underperform the broader stock market. • Integration of environmental, social, and/or governance (ESG) characteristics into the investment process may not work as intended. • The exclusion of certain issuers for reasons other than performance may negatively impact the Fund's performance. • The Fund may have high portfolio turnover, which could increase its transaction costs and an investor's tax liability.
Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI's express written consent.
228329